Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block

Anesthesia and Analgesia

Volumn 83, Issue 5, 1996, Pages 1076-1080

  Kirkegaard Nielsen, Hans ^a,b   Helbo Hansen, Hans S ^a   Lindholm, Peter ^a   Severinsen, Inge K ^a   Pedersen, Henrik S ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; FENTANYL; HALOTHANE; MIDAZOLAM; NITROUS OXIDE; THIOPENTAL;

ADULT; ANESTHETIC RECOVERY; ARTICLE; BODY MASS; BODY SURFACE; BODY WEIGHT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; PREDICTION; PRIORITY JOURNAL;

ADULT; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ANTHROPOMETRY; ATRACURIUM; BODY MASS INDEX; BODY SURFACE AREA; BODY WEIGHT; ELECTRIC STIMULATION; FEMALE; FORECASTING; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; OBESITY; REGRESSION ANALYSIS; TIME FACTORS; ULNAR NERVE;

EID: 0029972163     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199611000-00031     Document Type: Article

References (21)

1. Weinstein JA, Matteo RS, Ornstein E, et al. Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 1988;67:1149-53.
2. Kirkegaard-Nielsen H, Helbo-Hansen HS, Toft P, Severinsen IK. Anthropometric variables as predictors for duration of action of vecuronium-induced neuromuscular block. Anesth Analg 1994;79:1003-6.
3. Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg 1992;74:515-8.
4. Varin F, Ducharme J, Théorêt Y, et al. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharmacol Ther 1990;48:18-25.
5. Beemer GH, Bjorksten AR, Crankshaw DP. Effects of body build on the clearance of atracurium: implication for drug dosing. Anesth Analg 1993;76:1296-303.
6. Parker CJR, Hunter JM. Relationship between volume of distribution of atracurium and body weight. Br J Anaesth 1993;70:443-5.
7. Blobner M, Felber AR, Schneck HJ, Jelen-Esselborn S. Doseresponse relationship of atracurium in underweight, normal and overweight patients. Anasthesiol Intensivmed Notfallmed Schmerzther 1994;29:338-42.
8. Kirkegaard-Nielsen H, May O, Jensen AG, Lybecker H. Recovery from profound atracurium block evaluated by the post-tetanic count and time from last atracurium administration. Eur J Anaesthesiol 1990;7:389-94.
9. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;863-71.
10. 2) as a measure of fatness. Int J Obes 1985;9:147-53.
11. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
12. Kemsley WFF, Billewicz WZ, Thomson AM. A new weight-for-height standard based on British anthropometric data. Br J Prev Soc Med 1962;16:189-95.
13. New weight standards for men and women. Stat Bull Metrop Insur Co 1959;40:1-4.
14. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810-7.
15. Khaled MA, McCutcheon MJ, Reddy S, et al. Electrical impedance in assessing human body composition: the BIA method. Am J Clin Nutr 1988;47:789-92.
16. Hughes R, Payne JP. Clinical assessment of atracurium using the single twitch and tetanic responses of the adductor pollicis muscles. Br J Anaesth 1983;55(Suppl):47S-52S.
17. Parker CJR, Hunter JM, Snowdon SL. Effect of age, gender and anaesthetic technique on the pharmacodynamics of atracurium. Br J Anaesth 1993;70:38-41.
18. Beemer GH, Bjorksten AR. Pharmacodynamics of atracurium in clinical practice: effect of plasma potassium, patient demographics, and concurrent medication. Anesth Analg 1993;76:1288-95.
19. Abernethy DR, Greenblatt DJ, Divoll M, et al. Alterations in drug distribution and clearance due to obesity. J Pharmacol Exp Ther 1981;217:681-5.
20. Stenlake JB, Waigh RD, Urwin J, et al. Atracurium: conception and inception. Br J Anaesth 1983;55(Suppl):3S-10S.
21. Ward S, Weatherley BC. Pharmacokinetics of atracurium and its metabolites. Br J Anaesth 1986;58(Suppl):6S-10S.